To improve women’s access to pre-exposure prophylaxis (PrEP) in family planning (FP) clinics, we examined readiness to provide PrEP, and barriers and facilitators at the clinic level to integrate PrEP services into Title X-funded FP clinics across the Southern US. Title X-funded FP clinics across DHHS regions III (Mid-Atlantic), IV (Southeast), and VI (Southwest), comprising the Southern US. From February to June, 2018, we conducted a web-based, geographically targeted survey of medical staff, providers and administrators of Title X-funded FP clinics in DHHS regions III (Mid-Atlantic), IV (Southeast), and VI (Southwest). Survey items were developed using the Consolidated Framework for Implementation Research to assess constructs relevant to PrEP implementation. One-fifth of 283 unique Title X clinics across the South provided PrEP. Readiness for PrEP implementation was positively associated with a climate supportive of HIV prevention, leadership engagement, and availability of resources, and negatively associated with providers holding negative attitudes about PrEP’s suitability for FP. The Title X FP network is a vital source of sexual health care for millions of individuals across the US. Clinic-level barriers to providing PrEP must be addressed to expand onsite PrEP delivery in Title X FP clinics in the Southern US.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Centers for Disease Control and Prevention (CDC). HIV surveillance report, vol 28. 2016. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2016-vol-28.pdf. Published August 2016. Accessed 1 Sept 2019.
Hodder SL, Justman J, Haley DF, et al. Challenges of a hidden epidemic: HIV prevention among women in the United States. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S69–73.
Centers for Disease Control and Prevention (CDC). HIV Among Women. 2019. https://www.cdc.gov/hiv/group/gender/women/index.html. Published March 2019. Accessed 27 June 2019.
Centers for Disease Control and Prevention (CDC). CDC issue brief: HIV in the Southern United States. Updated May 2016. https://www.cdc.gov/hiv/pdf/policies/cdc-hiv-in-the-south-issue-brief.pdf. Published May 2016. Accessed 27 June 2019.
Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321(9):844–5. https://doi.org/10.1001/jama.2019.1343.
Food and Drug Administration (FDA). FDA approves first drug for reducing the risk of sexually acquired HIV infection. Washington, DC, 2012.
Centers for Disease Control and Prevention (CDC). High impact HIV prevention programs. https://www.cdc.gov/nchhstp/highimpactprevention/hiv-prevention-programs.html. Published October 2019. Accessed 1 Dec 2019.
NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html. Published August 2015. Accessed 1 Sept 2018.
Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195–216.
Smith DK, Van Handel M, Grey J. Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Ann Epidemiol. 2018;28(12):850–7.
Huang YA, Zhu W, Smith DK, Harris N, Hoover KW. HIV preexposure prophylaxis, by race and ethnicity—United States, 2014–2016. MMWR Morb Mortal Wkly Rep. 2018;67:1147–50.
Siegler AJ, Mouhanna F, Giler RM, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018;28(12):841–9.
Glasgow RE, Vinson C, Chambers D, Khoury MJ, Kaplan RM, Hunter C. National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health. 2012;102(7):1274–81.
Department of Health and Human Services. Program requirements for title X funded family planning projects. 2019. https://www.hhs.gov/opa/guidelines/program-guidelines/program-requirements/index.html. Published July 2019. Accessed 27 Jan 2020.
Fowler CI, Gable J, Wang J, Lasater B, Wilson E. Family planning annual report: 2018 national summary. Research Triangle Park, NC: RTI International. 2019. Published August 2019. Accessed 23 Dec 2019.
Auerbach JD, Kinsky S, Brown G, Charles V. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDs. 2015;29(2):102–10.
Stormo AR, Saraiya M, Hing E, Henderson JT, Sawaya GF. Women’s clinical preventive services in the United States: who is doing what? JAMA Intern Med. 2014;174(9):1512–4.
Frost JJ, Gold RB, Bucek A. Specialized family planning clinics in the United States: why women choose them and their role in meeting women’s health care needs. Women’s Health Issues. 2012;22(6):e519–25.
Jones RK, Sonfield A. Health insurance coverage among women of reproductive age before and after implementation of the affordable care act. Contraception. 2016;93(5):386–91.
Preexposure prophylaxis for the prevention of human immunodeficiency virus. Committee Opinion No. 595. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2014;123:1133–6. Reaffirmed, 2019.
Seidman D, Carlson K, Weber S, Witt J, Kelly PJ. United States family planning providers’ knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey. Contraception. 2016;93(5):463–9.
Wood BR, McMahan VM, Naismith K, Stockton JB, Delaney LA, Stekler JD. Knowledge, practices, and barriers to HIV preexposure prophylaxis prescribing among Washington state medical providers. Sex Transm Dis. 2018;45(7):452–8.
Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014;18(9):1712–21. https://doi.org/10.1007/s10461-014-0839-3.
Karris MY, Beekmann SE, Mehta SR, Anderson CM, Polgreen PM. Are we prepped for preexposure prophylaxis (PrEP)? provider opinions on the real-world use of PrEP in the United States and Canada. Clin Infect Dis. 2014;58(5):704–12. https://doi.org/10.1093/cid/cit796.
Mimiaga MJ, White JM, Krakower DS, Biello KB, Mayer KH. Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in Massachusetts. AIDS Care. 2014;26(6):684–93. https://doi.org/10.1080/09540121.2013.845289.
White JM, Mimiaga MJ, Krakower DS, Mayer KH. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS. 2012;26(7):395–405. https://doi.org/10.1089/apc.2012.0030.
Tripathi A, Ogbuanu C, Monger M, Gibson JJ, Duffus WA. Preexposure prophylaxis for HIV infection: healthcare providers’ knowledge, perception, and willingness to adopt future implementation in the southern US. South Med J. 2012;105(4):199–206. https://doi.org/10.1097/SMJ.0b013e31824f1a1b.
Tellalian D, Maznavi K, Bredeek UF, Hardy WD. Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDS. 2013;27(10):553–9. https://doi.org/10.1089/apc.2013.0173.
Shaeer K, Sherman E, Shafiq S, Hardigan P. Exploratory survey of Florida pharmacists’ experience, knowledge, and perception of HIV pre-exposure prophylaxis. J Am Pharm Assoc. 2014;54(6):610–7. https://doi.org/10.1331/JAPhA.2014.14014.
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;7(4):50.
Sales JM, Escoffery C, Hussen SA, et al. Pre-exposure prophylaxis integration into family planning services at title X clinics in the Southeastern United States: a geographically-targeted mixed methods study (Phase 1 ATN 155). JMIR Res Protoc. 2019;8(6):e12774. https://doi.org/10.2196/12774.
Norton WE. An exploratory study to examine intentions to adopt an evidence-based HIV linkage-to-care intervention among state health department AIDS directors in the United States. Implement Sci. 2012;7(1):27.
Ehrhart MG, Aarons GA, Farahnak LR. Assessing the organizational context for EBP implementation: the development and validity testing of the Implementation Climate Scale (ICS). Implement Sci. 2014;9(1):157.
Helfrich CD, Li YF, Sharp ND, Sales AE. Organizational readiness to change assessment (ORCA): development of an instrument based on the Promoting Action on Research in Health Services (PARIHS) framework. Implement Sci. 2009;4(1):38.
Cronbach LJJP. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297–334.
AIDSVu. 2015 HIV prevalence data. Emory University, Rollins School of Public Health. Atlanta, GA. www.aidsvu.org. Accessed 18 Nov 2018.
Profile of General Population and Housing Characteristics. 2010. 2010 Demographic Profile Data. U.S. Census Bureau, 2010 Census. https://factfinder.census.gov. Accessed 13 Nov 2018.
Ingram DD, Franco SJ. 2013 NCHS urban–rural classification scheme for counties. National Center for Health Statistics. Vital Health Stat. 2014;2(166):1–73.
Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons Inc; 2008.
van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16(3):219–42.
Cohen J, Cohen P. Applied multiple regression/correlation analysis for the behavioral sciences. L. Erlbaum Associates; 1983. ISBN: 9780898592689.
Siegler A, Bratcher B, Weiss KM. Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States. Am J Public Health. 2019;109(9):1216–23.
Berwick DM. Disseminating innovations in health care. JAMA. 2003;289(15):1969–75. https://doi.org/10.1001/jama.289.15.1969.
Institute of Medicine Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press; 2001.
Balas EA, Boren SA. In: Managing clinical knowledge for health care improvement. Yearbook of Medical Informatics. Medicine NLo. Bethesda MD, editor. 2000. pp. 65–70.
Dopson S, Locock L, Chambers D, Gabbay J. Implementation of evidence-based medicine: evaluation of the Promoting Action on Clinical Effectiveness programme. J Health Serv Res Policy. 2001;6:23–31. https://doi.org/10.1258/1355819011927161.
Durlak JA, DuPre EP. Implementation matters: a review of research on the influence of implementation on program outcomes and the factors affecting implementation. Am J Commun Psychol. 2008;41(3–4):327–50.
Holt D, Armenakis A, Harris S, Feild H. Toward a comprehensive definition of readiness for change: a review of research and instrumentation. Research in Organizational Change and Development. Amsterdam: JAI Press; 2006.
Armenakis AA, Harris SG, Mossholder KW. Creating readiness for organizational change. Hum Relat. 1993;46(6):681–703. https://doi.org/10.1177/001872679304600601.
Weiner BJ, Amick H, Lee SYD. Conceptualization and measurement of organizational readiness for change: a review of the literature in health services research and other fields. Med Care Res Rev. 2008;65(4):379–436. https://doi.org/10.1177/1077558708317802.
Sales JM, Piper K, Escoffery C, Sheth A. Where can Southern girls go for PrEP? Examining the PrEP-providing practices of Title X-funded family planning clinics across the Southern US. Paper to be presented at the 2020 Annual Meeting of the Society for Adolescent Health and Medicine, March 2020. San Diego, CA.
Department of Health and Human Services. Title X family planning grantees November 2019. https://www.hhs.gov/opa/title-x-family-planning/title-x-grantees/archive/index.html. Published November 2019. Accessed 23 Dec 2019.
Silapaswan A, Krakower D, Mayer KH. Pre-exposure prophylaxis: a narrative review of provider behavior and interventions to increase PrEP implementation in primary care. J Gen Intern Med. 2017;32(2):192–8.
Pinto RM, Berringer KR, Melendez R, Mmeje O. Improving PrEP implementation through multilevel interventions: a synthesis of the literature. AIDS Behav. 2018;22(11):3681–91.
Saberi P, Berrean B, Thomas S, Gandhi M, Scott H. A simple pre-exposure prophylaxis (PrEP) optimization intervention for health care providers prescribing PrEP: pilot study. JMIR Form Res. 2018;2(1):e2.
Spinelli MA, Scott HM, Vittinghoff E, et al. Brief report: a panel management and patient navigation intervention is associated with earlier PrEP initiation in a safety-net primary care health system. J Acquir Immune Defic Syndr. 2018;79(3):347–51.
Reback CJ, Clark KA, Runger D, Fehrenbacher AE. A promising PrEP navigation intervention for transgender women and men who have sex with men experiencing multiple syndemic health disparities. J Commun Health. 2019;44(6):1193–203.
Department of Health and Human Services. https://www.hhs.gov/opa/title-x-family-planning/fp-annual-report/fpar-infographic/index.html. Published August 2019. Accessed 30 Dec 2019.
Sales JM, Phillips AL, Tamler I, Munoz T, Cwiak C, Sheth AN. Patient recommendations for PrEP information dissemination at family planning clinics in Atlanta, Georgia. Contraception. 2019;99(4):233–8.
This research was supported by the National Institutes of Health Grant U24HD089880. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. A. Sheth receives funding from the National Institutes of Health (K23AI114407). L. Haddad’s effort is supported by the National Institutes of Health (K23HD078153).
Conflict of interest
J Sales received grant funding for an Investigator Sponsored Grant from Gilead Sciences, Inc. (CO-US-276-4060). A. Sheth also received grant funding from Gilead Sciences.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institution and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Sales, J.M., Escoffery, C., Hussen, S.A. et al. Pre-exposure Prophylaxis Implementation in Family Planning Services Across the Southern United States: Findings from a Survey Among Staff, Providers and Administrators Working in Title X-Funded Clinics. AIDS Behav (2021). https://doi.org/10.1007/s10461-020-03120-9
- Southern US
- HIV prevention
- Family planning